Whitfield Dianne C.
SEC insider (Form 3/4/5 filer). CIK 0001839516. Chief Human Resources Officer at Tarsus Pharmaceuticals, Inc. (TARS). 17 reported Form 4/5 transactions since Sep 2024; latest on Mar 19, 2026. Located in IRVINE, CA.
Companies Whitfield Dianne C. has filed insider reports for
- Tarsus Pharmaceuticals, Inc. (TARS): Officer, Chief Human Resources Officer
Whitfield Dianne C.
CIK: 0001839516
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tarsus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.2K shares at avg. $67.00$280K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4.1K shares at avg. $68.71$280K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect4K shares at avg. $69.42$280K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
ExerciseDirect23.9K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
17.2K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
27.3K shares- - Jan 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect5.7K shares at avg. $80.09$458K - Jan 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect893 shares at avg. $82.93$74K - Jan 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect835 shares at avg. $81.90$68K - Jan 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
SaleDirect8.1K shares at avg. $80.71$656K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,174 | $67.00 | $279,658 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,071 | $68.71 | $279,718 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,029 | $69.42 | $279,693 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise | 23,909 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Restricted Stock Units | 17,161 | - | - | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 27,310 | - | - | Direct |
| Jan 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,715 | $80.09 | $457,714 | Direct |
| Jan 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 893 | $82.93 | $74,056 | Direct |
| Jan 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 835 | $81.90 | $68,387 | Direct |
| Jan 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale | 8,122 | $80.71 | $655,527 | Direct |
1-10 of 17 transactions